CUSIP No. 98885E103
|
13G
|
Page 2 of 11 Pages
|
|||
1
|
NAME OF REPORTING PERSONS
Moshe Arkin
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
||||
3
|
SEC USE ONLY
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
|||
6
|
SHARED VOTING POWER
2,836,367 (*)
|
||||
7
|
SOLE DISPOSITIVE POWER
---
|
||||
8
|
SHARED DISPOSITIVE POWER
2,836,367 (*)
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,836,367 (*)
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.59% (*) (**)
|
||||
12
|
TYPE OF REPORTING PERSON (See instructions)
IN
|
CUSIP No. 98885E103
|
13G
|
Page 3 of 11 Pages
|
|||
1
|
NAME OF REPORTING PERSONS
Sphera Funds Management Ltd.
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
||||
3
|
SEC USE ONLY
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
|||
6
|
SHARED VOTING POWER
2,836,367 (*)
|
||||
7
|
SOLE DISPOSITIVE POWER
---
|
||||
8
|
SHARED DISPOSITIVE POWER
2,836,367 (*)
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,836,367 (*)
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.59% (*) (**)
|
||||
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. 98885E103
|
13G
|
Page 4 of 11 Pages
|
|||
1
|
NAME OF REPORTING PERSONS
Sphera Global Healthcare GP Ltd.
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
||||
3
|
SEC USE ONLY
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
|||
6
|
SHARED VOTING POWER
2,836,367 (*)
|
||||
7
|
SOLE DISPOSITIVE POWER
---
|
||||
8
|
SHARED DISPOSITIVE POWER
2,836,367 (*)
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,836,367 (*)
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.59% (*) (**)
|
||||
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
CUSIP No. 98885E103
|
13G
|
Page 5 of 11 Pages
|
|||
1
|
NAME OF REPORTING PERSONS
Sphera Global Healthcare Management LP
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
||||
3
|
SEC USE ONLY
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
---
|
|||
6
|
SHARED VOTING POWER
2,836,367 (*)
|
||||
7
|
SOLE DISPOSITIVE POWER
---
|
||||
8
|
SHARED DISPOSITIVE POWER
2,836,367 (*)
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,836,367 (*)
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.59% (*) (**)
|
||||
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
Item 1. (a) |
Name of Issuer:
|
(b) |
Address of Issuer's Principal Executive Offices:
|
Item 2. (a) |
Name of Person Filing:
|
(b) |
Address of Principal Business Office:
|
(c) |
Citizenship:
|
(d) |
Title of Class of Securities:
|
(e) |
CUSIP Number:
|
Item 3. |
Not applicable.
|
Item 4. |
Ownership:
|
(a) |
Amount beneficially owned:
|
• |
1,500,000 shares of Common Stock representing 4.01% of the total shares of Common Stock outstanding, are held directly by Sphera Global Healthcare Master Fund, which has delegated its investment management authority to Sphera Global
Healthcare Management Ltd. (the "Management Company").
|
• |
1,336,367 shares of Common Stock representing 3.58% of the total shares of Common Stock outstanding, are held directly by Sphera Biotech Master Fund, L.P., which has delegated its investment management authority to the Management
Company.
|
(b) |
Percent of class:
|
(c) |
Number of shares as to which such person has:
|
(i) |
Sole power to vote or to direct the vote:
|
(ii) |
Shared power to vote or to direct the vote:
|
(iii) |
Sole power to dispose or to direct the disposition of:
|
(iv) |
Shared power to dispose or to direct the disposition of:
|
Item 5. |
Ownership of Five Percent or Less of a Class:
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another:
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Item 8. |
Identification and Classification of Members of the Group:
|
Item 9. |
Notice of Dissolution of Group:
|
Item 10. |
Certification:
|
Moshe Arkin | ||
|
/s/ Moshe Arkin | |
By: Moshe Arkin | ||
Sphera Funds Management Ltd. |
|
/s/ Ori Goldfarb | |
By: Ori Goldfarb | ||
Title: Chief Executive Officer | ||
Sphera Global Healthcare GP Ltd. |
||
|
/s/ Ori Goldfarb | |
By: Ori Goldfarb | ||
Title: Chief Executive Officer | ||
Sphera Global Healthcare Management LP |
||
|
/s/ Doron Breen | |
By: Doron Breen | ||
Title: Managing Partner | ||
Exhibit 1 |
Joint Filing Agreement by and among the Reporting Persons, dated as of February 11, 2020.
|
Moshe Arkin | ||
|
/s/ Moshe Arkin | |
By: Moshe Arkin | ||
Sphera Funds Management Ltd. |
|
/s/ Ori Goldfarb | |
By: Ori Goldfarb | ||
Title: Chief Executive Officer | ||
Sphera Global Healthcare GP Ltd. |
||
|
/s/ Ori Goldfarb | |
By: Ori Goldfarb | ||
Title: Chief Executive Officer | ||
Sphera Global Healthcare Management LP |
||
|
/s/ Doron Breen | |
By: Doron Breen | ||
Title: Managing Partner | ||